Walgreens U.S. stores start administering Moderna, J&J COVID-19 booster
Oct 22 (Reuters) - Walgreens Boots Alliance Inc (WBA.O) said on Friday its U.S. stores started administering COVID-19 booster shots from Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N), a day after the country's health regulator recommended the additional doses.
The Centers for Disease Control and Prevention (CDC) on Thursday said Americans can also choose a different shot from their original inoculation as a booster.
Competitors Walmart Inc (WMT.N), Rite Aid Corp (RAD.N) and CVS Health Corp (CVS.N) did not immediately respond to Reuters request for comment on their plans to roll out J&J and Moderna vaccine boosters.
U.S. health regulators have recommended a second dose of J&J's single-dose COVID-19 vaccine for 18-year olds and above who received the first shot at least 2 months earlier.
They also recommended a third shot of Moderna's two-dose vaccine six months after the second dose for people aged at least 65 and those at high risk of severe disease and exposure to the virus through their jobs.
The FDA and CDC last month signed off on booster shots of the COVID-19 vaccine from Pfizer Inc (PFE.N) and partner BioNTech SE for the same groups as for Moderna.
U.S. pharmacy chains including Walgreens, Rite Aid and CVS began administering booster doses of Pfizer (PFE.N)/BioNTech at their stores on Sept. 24.
About 11.6 million people have received additional doses of Pfizer/BioNTech and Moderna vaccines since Aug. 13, when immunocompromised Americans started receiving additional doses.
Our Standards: The Thomson Reuters Trust Principles.